[Depression and antidepressive agents during treatments by prolonged-action neuroleptics. Side effects and "emergent metatherapeutic syndrome"].
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D003702:Delusions / Q000188:drug therapy; D003863:Depression / Q000139:chemically induced*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D011247:Pregnancy; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D013577:Syndrome; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000092864:Suicide Prevention
D000928:Antidepressive Agents; D003692:Delayed-Action Preparations; D014149:Tranquilizing Agents
Dépressions et antidépresseurs au cours des traitements par les neuroleptiques à effet prolongé. Effets secondaires et "syndrome émergent métathérapeutique"